Scientific article

Nouveaux traitements de l'hypertension pulmonaire en pédiatrie

Published inRevue médicale suisse, vol. 8, no. 329, p. 423-427
Publication date2012

Pulmonary arterial hypertension is a serious condition, with an estimated prevalence of 4 children over a million. Symptoms of this condition are not specific, leading to a potential delay in the diagnosis. Treatment of pediatric pulmonary hypertension is currently based on adult guidelines, using new targeted therapies, separated in 3 main categories: Endothelin receptor antagonists, prostacyclin and analogues, and phosphodiesterase type 5 inhibitors. These therapies improve symptoms and survival, but neither of them can cure the condition. Various new molecules are being currently tested in children or in development, offering hope to further improve the prognosis of pulmonary arterial hypertension.

  • Child
  • Humans
  • Hypertension, Pulmonary/drug therapy
Citation (ISO format)
WACKER BOU PUIGDEFABREGAS, Julie Caroline, TISSOT-DAGUETTE, Cécile, BEGHETTI, Maurice. Nouveaux traitements de l’hypertension pulmonaire en pédiatrie. In: Revue médicale suisse, 2012, vol. 8, n° 329, p. 423–427.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation10/24/2013 10:44:00 AM
First validation10/24/2013 10:44:00 AM
Update time03/14/2023 8:40:20 PM
Status update03/14/2023 8:40:20 PM
Last indexation01/16/2024 8:21:00 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack